OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 5.74
-0.61 (-9.61%)
At close: Mar 9, 2026
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 80.64 million as of March 9, 2026. Its market cap has increased by 24.49% in one year.
Market Cap
80.64M
Enterprise Value
84.42M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.74
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 80.64M, a decrease of -9.42%. That is a compound annual growth rate of -1.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 89.21M | 4.34% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scandinavian ChemoTech AB | 88.33M |
| Spago Nanomedical AB | 83.36M |
| Biosergen AB | 89.23M |
| Biovica International AB | 96.33M |
| Annexin Pharmaceuticals AB | 102.36M |
| Alligator Bioscience AB | 104.66M |
| Active Biotech AB | 118.89M |
| Alzinova AB | 61.66M |